In re Iovance Biotherapeutics, Inc. Securities Litigation — Entry #97: ORDER granting 95 Joint Stipulation Regarding Case Schedule
Case: In re Iovance Biotherapeutics, Inc. Securities Litigation cand · 5:25-cv-04177
filed May 15, 2025
What this document is
Docket entry #97 · filed January 20, 2026
ORDER granting 95 Joint Stipulation Regarding Case Schedule. Signed by Judge Eumi K. Lee. (lrt, COURT STAFF) (Filed on 1/20/2026) (Entered: 01/20/2026)
Who is involved
- Anthony Westfall
- Brian Paplaski
- Daniel G. Kirby
- Dimitry Farberov
- Elliot Resnick
- Frederick G. Vogt
- Gary LoPiccolo
- Hassan Pourhossein
- Igor P. Bilinsky
- Iovance Biotherapeutics, Inc.
- Jean-Marc Bellemin
- JianJun Wei
- Karthik Trichur Sundaram
- Lindy Merrill
- Mark van den Broek
- Mehdi Hasan
- Peter Jay Guthy
- Samhita Gera
- The Iova Investor Group
- Thor Brevik
- Tony Djie
Why we have it
We follow this case because it names a company we track, although that company is not a party:
- Riot: its former name “Riot Blockchain, Inc.” appears in a filing in this case.
…compel a different result. See Takata v. Riot Blockchain, Inc., 2018 WL 5801379, at *5 (D.N.J. 8 Nov…
- Applied Digital: its former name “FLIGHT SAFETY TECHNOLOGIES INC” appears in a filing in this case.
…Co-Lead Counsel. $1.2 million. Flight Safety Technologies, Inc., (D. Conn.). Rosen Lead Counsel. $1…
- Core Scientific: its name “Core Scientific, Inc.” appears in a filing in this case.
…Page 22 of 23 Pang v. Levitt (Core Scientific, Inc.), No. 22-CV-1191-LY (W.D. Tex.). Rosen…
A free copy from the RECAP archive of federal court filings (mirrored at the Internet Archive), retrieved October 20, 2026. Federal court filings are public records.
Document text
4 page(s), 8,665 characters, converted from the PDF's text layer · plain text.
Full text
Case 5:25-cv-04177-EKL Document 97 Filed 01/20/26 Page 1 of 4
1 THE ROSEN LAW FIRM, P.A.
Laurence M. Rosen (SBN 219683)
2 355 South Grand Avenue, Suite 2450
Los Angeles, CA 90071
3 Telephone: (213) 785-2610
Facsimile: (213) 226-4684
4 Email: [email protected]
5 [Additional Counsel on Signature Page]
6
7
8 UNITED STATES DISTRICT COURT
9 NORTHERN DISTRICT OF CALIFORNIA
10 SAN JOSE
11
12 Case No.: 5:25-cv-04177-EKL
In re Iovance Biotherapeutics, Inc. Securities
13 Litigation
JOINT STIPULATION AND
14 [PROPOSED] ORDER REGARDING
CASE SCHEDULE
15
16
Judge: Hon. Eumi K. Lee
17 Courtroom: 7 – 4th Floor
18
19
20
21
22
23
24
25
26
27
28
JOINT STIPULATION AND [PROPOSED] CASE NO. 5:25-cv-04177-EKL
ORDER RE CASE SCHEDULE
Case 5:25-cv-04177-EKL Document 97 Filed 01/20/26 Page 2 of 4
1 Court appointed Lead Plaintiff Lindy Merrill and Tony Djie (“Plaintiff”) and Defendants
2 Iovance Biotherapeutics, Inc., Frederick G. Vogt, Jean-Marc Bellemin, Igor Bilinksy, and Daniel G.
3 Kirby (collectively, “Defendants”), by and through their respective counsel, respectfully submit this
4 Stipulation and [Proposed] Order setting forth a schedule for the filing of an amended complaint, a
5 motion to dismiss, an opposition to the motion to dismiss, and a reply to the opposition to the motion
6 to dismiss.
7 WHEREAS, on December 15, 2025, the Court entered an Order Appointing Lead Plaintiff
8 and Lead Counsel which requires the parties to submit a proposed schedule for the filing of a
9 consolidated or amended complaint and Defendants’ responsive pleading within thirty days [Docket
10 No. 92];
1 WHEREAS, Plaintiff presently intends to file an amended complaint;
13 WHEREAS, the Defendants presently intend to move to dismiss any complaint in this action;
14 WHEREAS, pursuant to the PSLRA, all discovery and other proceedings in this action are
15 stayed pending the determination of the Defendants’ planned motion to dismiss;
16 NOW, THEREFORE, Plaintiff and the Defendants stipulate and agree, subject to approval
17 of the Court, as follows:
18 1. Plaintiff shall file an amended complaint (the “CAC”) by March 16, 2026;
19 2. The Defendants shall answer or otherwise respond to the CAC by May 15,
20 2026;
21 3. If a motion to dismiss is filed, Plaintiff shall file any opposition by July 14,
22 2026;
23 4. The Defendants shall file any reply by August 13, 2026.
24
Dated: January 14, 2026 THE ROSEN LAW FIRM, P.A.
25 Laurence M. Rosen (SBN 219683)
355 South Grand Avenue, Suite 2450
26 Los Angeles, CA 90071
Telephone: (213) 785-2610
27 Facsimile: (213) 225-4684
Email: [email protected]
28
STIPULATION AND [PROPOSED] CASE NO. 5:25-cv-04177-EKL
ORDER RE CASE SCHEDULE 1
Case 5:25-cv-04177-EKL Document 97 Filed 01/20/26 Page 3 of 4
1 THE ROSEN LAW FIRM, P.A.
Phillip C. Kim (admitted pro hac vice)
2 Sara Fuks (admitted pro hac vice)
275 Madison Avenue- 40th Floor
3 New York, NY 10016
Telephone: (212) 686-1060
4 Email: [email protected]
5 By: /s/ Sara Fuks
Sara Fuks
6
7
Lead Counsel for Lead Plaintiff and the Class
8
THE SCHALL LAW FIRM
9
Brian Schall (290685)
10 2049 Century Park East, Suite 2460
Los Angeles, CA 90067
1 Telephone: (310) 301-3335
[email protected]
13
Additional Counsel for Lead Plaintiff and the
14 Class
15 Dated: January 14, 2026 ARNOLD & PORTER KAYE SCHOLER
LLP
16 Tommy Huynh
Three Embarcadero Center, 10th Floor
17 San Francisco, CA 94111
Telephone: +1 415 471 3147
18 Facsimile: +1 415 471 3400
[email protected]
19
ARNOLD & PORTER KAYE SCHOLER
20 LLP
Aaron Frank Miner- admitted pro hac vice
21 Veronica E. Callahan- admitted pro hac vice
250 West 55th Street
22 New York, NY 10019
Telephone: + 212-836-8000
23 [email protected]
[email protected]
24
ARNOLD & PORTER KAYE SCHOLER
25 LLP
Stephanna F. Szotkowski-admitted pro hac vice
26 70 West Madison Street
Suite 4200
27 Chicago, IL 60602
Telephone: 312-583-2354
28 [email protected]
STIPULATION AND [PROPOSED] CASE NO. 5:25-cv-04177-EKL
ORDER RE CASE SCHEDULE 2
Case 5:25-cv-04177-EKL Document 97 Filed 01/20/26 Page 4 of 4
1
2
3 By: /s/ Tommy Huynh
4
Counsel for Defendants Iovance
5 Biotherapeutics, Inc., Frederick Vogt, Jean-
Marc Bellemin, Igor P. Bilinsky, and Daniel G.
6 Kirby
7
8
SIGNATURE ATTESTATION
9
Pursuant to Local Civil Rule 5-1(h)(3), I attest under penalty of perjury that each of the other
10
signatories have concurred in the filing of this document.
1
January 14, 2026 By: /s/ Sara Fuks
13
Sara Fuks
14
15 IT IS SO ORDERED
16
17
January 20
Dated: ______________, 2026
18 Hon. Eumi K. Lee
United States District Court Judge
19
20
21
22
23
24
25
26
27
28
STIPULATION AND [PROPOSED] CASE NO. 5:25-cv-04177-EKL
ORDER RE CASE SCHEDULE 3